ACT Biotech Obtains $500,000 New Funding

  • Feed Type
  • Date
    12/31/2009
  • Company Name
    ACT Biotech
  • Mailing Address
    717 Market Street San Francisco, CA 94103-2103
  • Company Description
    ACT Biotech is a San Francisco-based privately-held pharmaceutical company focused exclusively on the development and commercialization of targeted cancer drugs.
  • Website
    http://www.actbiotech.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    NGN Capital
  • Venture Investor
    Undisclosed

Trending on Xconomy